Commit Biologics ApS
Private limited companyCVR 42642649Aarhus CActive
Commit Biologics ApS is a private limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 33.8m. With 24 employees, the company is about 5 times larger than the industry median. Equity grew to DKK 37.9m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 39.4m to DKK 33.8m (2024 → 2025).
- Equity rose 63% (2024 → 2025), to DKK 37.9m.
Employees
- 6 more employees than a year earlier: 24 (07/2026) against 18 (07/2025).
Management and owners, last 24 months
- New in management: Janine Schuurman (board member, 23/12/2024), Thomas Lars Andresen (ceo, 16/03/2026) and Thomas Lars Andresen (board member, 16/03/2026) (+4).
- Stepped down: Krishna Reddy Polu (ceo, 11/01/2025), Krishna Reddy Polu (board member, 11/01/2025) and Eva Van Overmeire (board member, 01/10/2026) (+2).
- New owners registered: Novo Holdings A/S (08/01/2026), Commit Biologics Holding ApS (08/01/2026) and Bioqube Factory Fund I CommV (08/01/2026) (+2).
- No longer registered as owner: Novo Holdings A/S (07/01/2026), Commit Biologics Holding ApS (07/01/2026) and Bioqube Factory Fund I CommV (07/01/2026) (+1).
Registrations, last 24 months
- 08/01/2026: Share capital changed from 177,413 DKK to 208,371 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 23/12/2024: Share capital changed from 130,978 DKK to 177,413 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | −13,580 | −31,408 | −23,365 | +25.6% |
| Operating profit (EBIT) | −20,775 | −45,477 | −39,469 | +13.2% |
| Profit before tax | −20,531 | −44,861 | −39,281 | +12.4% |
| Net profit | −17,296 | −39,361 | −33,781 | +14.2% |
| Total assets | 23,326 | 24,451 | 38,808 | +58.7% |
| Equity | 22,579 | 23,218 | 37,898 | +63.2% |
| Liabilities | 747 | 1,233 | 910 | −26.2% |
| Cash and cash equivalents | 18,260 | 16,409 | 30,390 | +85.2% |
| Average number of employees | 10 | 13 | 17 | +30.8% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 15/04/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 16/04/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 24/05/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 9,869of 9,892 Better than 0% | No. 945of 9,922 Better than 90% |
| Same industry and 20–49 employees64 companies in the comparison | No. 56of 62 Better than 10% | No. 26of 64 Better than 60% |
| Companies that are between 5 and 14 years old33,679 companies in the comparison | No. 33,545of 33,579 Better than 0% | No. 1,473of 33,678 Better than 96% |
| All companies of type ApS66,508 companies in the comparison | No. 66,341of 66,379 Better than 0% | No. 2,637of 66,505 Better than 96% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Commit Biologics ApS−DKK 23.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Commit Biologics ApS−DKK 33.8m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Commit Biologics ApSDKK 37.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Commit Biologics ApS24
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Holdings A/S25%
- Commit Biologics Holding ApS15%
- Bioqube Factory Fund I CommV25%
- Korys Investments15%
Management
8 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Thomas Lars Andresen | CEO | 16/03/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Pieter Jeroen Bakker | Board member | 30/12/2022 |
| Nick Stub Laursen | Board member | 30/12/2022 |
| Roderick Verhelst | Board member | 30/12/2022 |
| Anker Gunvald Lundemose | Chair of the board | 01/02/2023 |
| Janine Schuurman | Board member | 23/12/2024 |
| Thomas Lars Andresen | Board member | 16/03/2026 |
| Emiel Michiels | Board member | 01/10/2026 |
- Founders
- Commit Biologics Holding ApS
Former management (9)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Nick Stub Laursen | Director | 01/09/2021 | 24/08/2023 |
| Dennis Vestergaard Pedersen | Director | 01/09/2021 | 30/12/2022 |
| Heidi Gytz Olesen | Director | 01/09/2021 | 30/12/2022 |
| Mikael Becher Lykkegaard Winkler | Director | 01/09/2021 | 30/12/2022 |
| Krishna Reddy Polu | CEO | 24/08/2023 | 11/01/2025 |
| Krishna Reddy Polu | Board member | 24/08/2023 | 11/01/2025 |
| Eva Van Overmeire | Board member | 23/12/2024 | 01/10/2026 |
| Mikkel Wandahl Pedersen | CEO | 11/01/2025 | 16/03/2026 |
| Mikkel Wandahl Pedersen | Board member | 10/07/2025 | 16/03/2026 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Address and production units
2 active production unitsUniversitetsbyen 81
8000 Aarhus C
Aarhus Municipality · Postcode 8000
Other companies at the address (1)
- SymbioMatch ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Commit Biologics ApS | Universitetsbyen 81, 8000 Aarhus C | 19 | 1027490960 |
| Commit Biologics ApS | Nordre Fasanvej 215, 2000 Frederiksberg | – | 1031763483 |
Purpose
Selskabets formål er fremstilling af farmaceutiske præparater, forskning og eksperimentel udvikling indenfor bioteknologi.
The purpose is quoted from the register in Danish.
Changes year by year
60 registered events202616 changesmanagement 6 · accounts 1 · capital 1 · ownership 8
- ManagementEmiel Michiels appointed board member
- ManagementEva Van Overmeire stepped down as board member
- AccountsAnnual report for 2025 published
- ManagementThomas Lars Andresen appointed ceo
- ManagementThomas Lars Andresen appointed board member
- ManagementMikkel Wandahl Pedersen stepped down as board member
- ManagementMikkel Wandahl Pedersen stepped down as ceo
- CapitalShare capital changed from 177,413 DKK to 208,371 DKK
- OwnershipKorys Investments registered as owner (15%)
- OwnershipBioqube Factory Fund I CommV registered as owner (25%)
- OwnershipCommit Biologics Holding ApS registered as owner (15%)
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipKorys Investments is no longer registered as owner
- OwnershipCommit Biologics Holding ApS is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipBioqube Factory Fund I CommV is no longer registered as owner
20256 changesmanagement 4 · accounts 1 · industry 1
- ManagementMikkel Wandahl Pedersen appointed board member
- AccountsAnnual report for 2024 published
- ManagementMikkel Wandahl Pedersen appointed ceo
- ManagementKrishna Reddy Polu stepped down as ceo
- ManagementKrishna Reddy Polu stepped down as board member
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202414 changescapital 2 · management 2 · ownership 8 · accounts 1 · address 1
- CapitalShare capital changed from 130,978 DKK to 177,413 DKK
- ManagementEva Van Overmeire appointed board member
- ManagementJanine Schuurman appointed board member
- OwnershipKorys Investments registered as owner (10%)
- AccountsAnnual report for 2023 published
- AddressMoved to Universitetsbyen 81, 8000 Aarhus C
- CapitalShare capital changed from 87,968 DKK to 130,978 DKK
- OwnershipCommit Biologics Holding ApS registered as owner (20%)
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipBioqube Factory Fund I CommV registered as owner (25%)
- OwnershipBII Holdings A/S is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipBioqube Factory Fund I CommV is no longer registered as owner
- OwnershipCommit Biologics Holding ApS is no longer registered as owner
20236 changesmanagement 4 · ownership 2
- ManagementKrishna Reddy Polu appointed ceo
- ManagementKrishna Reddy Polu appointed board member
- ManagementNick Stub Laursen stepped down as director
- OwnershipBII Holdings A/S registered as owner (5%)
- OwnershipBioInnovation Institute Fonden is no longer registered as owner
- ManagementAnker Gunvald Lundemose appointed chair of the board
202212 changescapital 1 · management 6 · ownership 5
- CapitalShare capital changed from 40,000 DKK to 87,968 DKK
- ManagementNick Stub Laursen appointed board member
- ManagementPieter Jeroen Bakker appointed board member
- ManagementRoderick Verhelst appointed board member
- ManagementMikael Becher Lykkegaard Winkler stepped down as director
- ManagementHeidi Gytz Olesen stepped down as director
- ManagementDennis Vestergaard Pedersen stepped down as director
- OwnershipNovo Holdings A/S registered as owner (20%)
- OwnershipBioqube Factory Fund I CommV registered as owner (20%)
- OwnershipCommit Biologics Holding ApS registered as owner (33.33%)
- OwnershipBioInnovation Institute Fonden registered as owner (5%)
- OwnershipCommit Biologics Holding ApS is no longer registered as owner
20216 changesfounded 1 · management 4 · ownership 1
- FoundedRegistered as Commit Biologics ApS
- ManagementNick Stub Laursen appointed director
- ManagementMikael Becher Lykkegaard Winkler appointed director
- ManagementHeidi Gytz Olesen appointed director
- ManagementDennis Vestergaard Pedersen appointed director
- OwnershipCommit Biologics Holding ApS registered as owner (100%)
Related companies
Same industry in Aarhus
- Vestas Wind Systems A/S3,108 employees
- SEGES Innovation P/S520 employees
- Alx A/S109 employees
- NMD Pharma A/S64 employees
- Innovationscenter for Økologisk Landbrug P/S52 employees
- Cercare Medical A/S28 employees
Same people in management
- Servier Symphogen A/Svia Anker Gunvald Lundemose
- Adcendo ApSvia Pieter Jeroen Bakker
- Saniona A/Svia Anker Gunvald Lundemose
- de novo foundry ApSvia Pieter Jeroen Bakker
- Antag Therapeutics ApSvia Anker Gunvald Lundemose
- MonTa Biosciences ApSvia Thomas Lars Andresen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.